Skip to main content

CV Sciences, Inc.

corporate_fare Company Profile

CV Sciences, Inc.

Exchange: OTCSector: Life Sciences

show_chartPrice Chart

Loading chart...

feed CVSI - Latest Insights

CVSI
Apr 14, 2026, 9:15 PM EDT
Filing Type: DEF 14A
Importance Score:
8
CV Sciences Seeks Shareholder Approval for Reverse Stock Split Authorization to Facilitate Nasdaq Listing
Sentiment: Negative
View Wiseek Article
CVSI
Apr 10, 2026, 4:04 PM EDT
Filing Type: 8-K
Importance Score:
9
CV Sciences Halves Convertible Note Price to $0.03, Issues New Debt Amidst Going Concern
Sentiment: Negative
View Wiseek Article
CVSI
Mar 26, 2026, 5:14 PM EDT
Filing Type: 10-K
Importance Score:
9
Annual Report Reveals Going Concern, Critical Regulatory Headwinds, and Dilutive Debt Restructuring
Sentiment: Negative
View Wiseek Article
CVSI
Mar 26, 2026, 4:06 PM EDT
Filing Type: 8-K
Importance Score:
7
CV Sciences Reports Q4 Adjusted EBITDA Turns Positive Amidst Revenue Decline
Sentiment: Neutral
View Wiseek Article
CVSI
Mar 10, 2026, 5:16 PM EDT
Filing Type: 8-K
Importance Score:
9
CV Sciences Restructures Debt with Highly Dilutive Convertible Notes and Open-Ended True-Up Provision
Sentiment: Negative
View Wiseek Article
CVSI
Mar 10, 2026, 5:00 PM EDT
Source: Acceswire
Importance Score:
8
CV Sciences Restructures Debt with Conversion Feature at $0.06/Share to Boost Financial Health
Sentiment: Positive
View Wiseek Article